Press Releases and Media Coverage

Cures Within Reach is the only disease-agnostic, not-for-profit organization exclusively dedicated to using the speed, safety and cost-effectiveness of already approved drugs, devices, diagnostics, nutraceuticals and combination products to impact patients with unmet medical needs – driving more treatments to more patients more quickly.

Here are some of our press releases, videos of events, presentations and other media coverage. Please contact us at info@cureswithinreach.org for more information on our research, donor-advised philanthropy, patient education events and more.

Press Releases

2024

December 17, 2024: Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches. Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives

December 9, 2024: Cures Within Reach and Open Philanthropy Expand Partnership to Address Factors that Lead to High Disease Burden in Low / Lower-Middle Income Countries. Cures Within Reach will fund 16 additional clinical trials in next two years.

August 14, 2024: Two Clinical Trials Impacting US Veterans Now Underway. Cures Within Reach will select two more veterans’ focused clinical trials later in 2024.

January 23, 2024: Four clinical trials impacting high disease burden in LMICs will start soon. Cures Within Reach also announces its latest success story and a multi-year grant from Open Philanthropy focused on LMICs.

click here to see ALL our press releases.

Cures Within Reach quoted in USA Today: “Could treatments for rare disease be found in neighborhood pharmacies? New uses for old drugs offer promise “, Dec 2021

Cures Within Reach featured in Inside Philanthropy: “Hiding in Plain Sight: A Funder Hunting for Lifesaving Alternate Uses for Existing Treatments”, July 2021

DIA Podcast: Cures Within Reach and Impact Philanthropy